Final Program

MONDAY • MAY 16 147
221 Methamphetamine Abuse and Health Care Burden of a Single
Tertiary Referral Center in the Central Valley of California/P.
Doddamreddy, J. Tulyagankhodjaev, C. Ives, J. Rosario, V.
Balasubramanian, P. Armenian, R. Vohra, Fresno, CA, p.A2959
222 Trends in Heroin- and Prescription Opioid-Related Intensive
Care Unit Admissions Between 2008-2014/D. Hsu, A. Law, J.
Marshall, S. O’Donoghue, J. Bertone, J.P. Stevens, Boston, MA,
p.A2960
223 Trends in Hospital Admissions and Costs associated with
Heroin and Prescription Opioid Overdoses: Analysis of
National Inpatient Sample Data 2001-2012/D. Hsu, E. McCarthy,
J.P. Stevens, K. Mukamal, Boston, MA, p.A2961
224 Intermediate Care Resource Utilization Among Patients
Hospitalized with Pneumonia/A.J. Admon, H. Wunsch, T.J.
Iwashyna, C.R. Cooke, Ann Arbor, MI, p.A2962
225 Patterns of Non-Invasive Home Ventilation Usage in the
Province of Alberta, Canada: A Retrospective
Population-Based Cohort Study/E.J. MacIntyre, K. Rimmer, C.
Cyr, D.A. McKim, M. Chan, M. Heule, A. Massia, L. Rose, S.M.
Bagshaw, Edmonton, Canada, p.A2963
B23
POSTER DISCUSSION SESSION
CARDIOVASCULAR AND RESPIRATORY
INTERACTIONS IN COPD
9:00 a.m. - 11:00 a.m. MOSCONE CENTER
Room 133 (North Building, Lower Level)
Poster Viewing 9:00-9:45
Discussion 9:45-11:00
Chairing: R.G. Barr, MD, DrPH, New York, NY
M.J. Cuttica, MD, Chicago, IL
J.M. Wells, MD, Birmingham, AL
101 Airflow Limitation and Endothelial Dysfunction: Unrelated and
Independent Predictors of Atherosclerosis/D. Chandra, A.
Gupta, P.J. Strollo, C. Fuhrman, J.K. Leader, J.M. Bon, W.A.
Slivka, K.E. Kip, S. Reis, F.C. Sciurba, Pittsburgh, PA, p.A2964
102 Tricuspid Annular Plane Systolic Excursion (TAPSE) as a
Predictor of Long Term Survival in Hospitalized Patients with
Chronic Obstructive Pulmonary Disease/M. Diamond, J. Barry,
V. Lakhter, K. Shenoy, M. Keane, G.J. Criner, Philadelphia, PA,
p.A2965
103 Growth Differentiation Factor-15 (GDF-15) Levels in Chronic
Obstructive Pulmonary Disease Are Independently Associated
with Subclinical Coronary Atherosclerosis: An Analysis of the
COPDGene Cohort/C.H. Martinez, C.M. Freeman, J.D. Nelson,
M.J. Budoff, S. Murray, X. Wang, S.P. Bhatt, R.P. Bowler, M.T.
Dransfield, L. Guo, J. Hokanson, G.L. Kinney, F.J. Martinez, E.A.
Regan, J.M. Wells, M.K. Han, J.L. Curtis, Ann Arbor, MI, p.A2966
104 Impact of Cardiovascular Co-Morbidities on FEV1 Change in
Smokers: An Analysis of the COPDGene Cohort/D.J. Maselli,
A.A. Diaz, V. Kim, N. Putcha, M.J. Budoff, E.J. Van Beek, M.G.
Foreman, G.L. Kinney, J. Hokanson, J.L. Curtis, F.J. Martinez, A.
Tadashi, R.P. Bowler, E.A. Regan, B.J. Make, N.A. Hanania, M.K.
Han, C.H. Martinez, San Antonio, TX, p.A2967
105 Heart-Lung Interaction in a Model of COPD: The Importance of
Lung Volume/W.S. Cheyne, A.M. Williams, M.I. Harper, N.D.
Eves, Kelowna, Canada, p.A2968
106 Volume Loading Exacerbates Adverse Heart-Lung Interaction
in a Model of COPD/W.S. Cheyne, A.M. Williams, M.I. Harper,
N.D. Eves, Kelowna, Canada, p.A2969
107 Lack of Change in Arterial Stiffness and Vascular Function in
Chronic Obstructive Pulmonary Disease Patients Admitted to
Hospital/I.J. Andresson, D. Fuhr, M. Bhutani, R. Damant, B.H.
Rowe, R. Leigh, M. Stickland, Edmonton, Canada, p.A2970
108 A Randomized Trial of Once-Daily Fluticasone
Furoate/Vilanterol or Vilanterol Versus Placebo to Determine
Their Effects on Arterial Stiffness in COPD/S.P. Bhatt, M.T.
Dransfield, J.R. Cockcroft, J. Wang-Jairaj, D.A. Midwinter, D.B.
Rubin, C.A. Scott-Wilson, C. Crim, Birmingham, AL, p.A2971
109 The Relationship Between Airflow Obstruction and Severity of
Coronary Arterial Disease in Smokers and Non-Smokers/S.
Ruickbie, A. Prasad, P.W. Jones, E.H. Baker, London, United
Kingdom, p.A2972
110 Effect of Nasal High Flow on Digital Vascular Tone During
Sleep in COPD Patients/K. Fricke, H. Schneider, L. Grote,
Baltimore, MD, p.A2973
111 Atrial Arrhythmia and Diastolic Dysfunction Are Associated
with Acute Exacerbation of COPD/P. Schroff, J.M. Wells, Y.-I.
Kim, J.E. Blalock, W.C. Bailey, M.T. Dransfield, S.P. Bhatt,
Birmingham, AL, p.A2974
112 Eligibility for the STATCOPE Trial: A Review of Statin Use in a
Hospital-Based Cohort of COPD Patients/R.P. Young, C. Chen,
R.J. Hopkins, G.D. Gamble, Auckland, New Zealand, p.A2975
113 Pulmonary Hypertension in COPD from Exposure to Biomass
Fuel/M. Gholamnejad, Y. Roosta, Urmia, Iran, p.A2976
114 Evaluation of T Peak-T End Interval in Patients with Chronic
Obstructive Pulmonary Disease (COPD)/G. Karadeniz, F.
Ucsular, M. Demir, S. Bulac Kir, S. Doruk, Izmir, Turkey, p.A2977
115 Plasma von Willebrand Factor and Longitudinal Change in
Percent Emphysema: The MESA Lung Study/C.P. Aaron, E.A.
Hoffman, M.F. Doyle, J.E. Schwartz, E.C. Oelsner, N.B. Larson,
S.J. Bielinski, S.M. Kawut, R.G. Barr, New York, NY, p.A2978
116 Association of Airflow Limitation with Carotid Atherosclerosis
in a Japanese Community: The Hisayama Study/K. Kunihiro, K.
Matsumoto, J. Hata, Y. Shundo, S. Fukuyama, H. Inoue, Y.
Kiyohara, T. Ninomiya, Y. Nakanishi, Fukuoka, Japan, p.A2979
117 Association of Chronic Obstructive Pulmonary Disease
(COPD) and Diabetes Mellitus with Cardiovascular Diseases;
and Review of Health-Care Associated Costs’ for COPD
Patients from the Medical Expenditure Panel Survey (MEPS)
Dataset/I.A. Lalani, L. Liu, Long Branch, NJ, p.A2980
MONDAY MORNING
ATS 2016 • San Francisco